Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pre-Exposure Prophylaxis | 7 | 2019 | 34 | 2.420 |
Why?
|
| HIV Infections | 10 | 2019 | 2134 | 1.350 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2019 | 573 | 0.740 |
Why?
|
| Disease Transmission, Infectious | 2 | 2018 | 94 | 0.730 |
Why?
|
| Health Plan Implementation | 1 | 2018 | 90 | 0.610 |
Why?
|
| Program Evaluation | 1 | 2018 | 597 | 0.520 |
Why?
|
| Consumer Behavior | 1 | 2014 | 46 | 0.500 |
Why?
|
| Homosexuality, Male | 5 | 2023 | 71 | 0.480 |
Why?
|
| Sexual and Gender Minorities | 4 | 2023 | 63 | 0.460 |
Why?
|
| Emergency Service, Hospital | 1 | 2015 | 1148 | 0.300 |
Why?
|
| Mass Screening | 1 | 2015 | 1509 | 0.290 |
Why?
|
| Anti-HIV Agents | 3 | 2019 | 350 | 0.280 |
Why?
|
| Urban Population | 3 | 2019 | 269 | 0.270 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2023 | 1209 | 0.270 |
Why?
|
| Papillomavirus Infections | 2 | 2023 | 980 | 0.250 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2023 | 1105 | 0.250 |
Why?
|
| Texas | 5 | 2019 | 6311 | 0.240 |
Why?
|
| Social Networking | 2 | 2019 | 28 | 0.200 |
Why?
|
| Qualitative Research | 3 | 2019 | 556 | 0.180 |
Why?
|
| Health Services Administration | 1 | 2018 | 13 | 0.160 |
Why?
|
| Sexual Partners | 2 | 2018 | 112 | 0.160 |
Why?
|
| Health Personnel | 1 | 2023 | 625 | 0.150 |
Why?
|
| Syphilis | 1 | 2018 | 61 | 0.150 |
Why?
|
| Chemoprevention | 1 | 2018 | 241 | 0.140 |
Why?
|
| Health Services Research | 1 | 2018 | 233 | 0.140 |
Why?
|
| Coinfection | 1 | 2018 | 189 | 0.140 |
Why?
|
| Viral Load | 1 | 2018 | 493 | 0.140 |
Why?
|
| Hospitals, Urban | 1 | 2015 | 87 | 0.130 |
Why?
|
| Young Adult | 7 | 2019 | 21445 | 0.130 |
Why?
|
| Boston | 1 | 2014 | 108 | 0.130 |
Why?
|
| Condoms | 1 | 2014 | 53 | 0.130 |
Why?
|
| Meningoencephalitis | 1 | 2014 | 24 | 0.120 |
Why?
|
| Focus Groups | 1 | 2014 | 256 | 0.120 |
Why?
|
| Health Behavior | 1 | 2018 | 603 | 0.110 |
Why?
|
| Health Services Accessibility | 3 | 2019 | 761 | 0.110 |
Why?
|
| Adult | 10 | 2019 | 77950 | 0.110 |
Why?
|
| Adolescent | 6 | 2019 | 31252 | 0.100 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2014 | 362 | 0.100 |
Why?
|
| Chagas Disease | 1 | 2014 | 277 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2014 | 1225 | 0.090 |
Why?
|
| Male | 10 | 2023 | 123000 | 0.090 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2009 | 70 | 0.080 |
Why?
|
| Uncompensated Care | 1 | 2008 | 11 | 0.080 |
Why?
|
| Social Work | 1 | 2008 | 24 | 0.080 |
Why?
|
| Labor, Obstetric | 1 | 2009 | 86 | 0.080 |
Why?
|
| AIDS Serodiagnosis | 1 | 2009 | 61 | 0.080 |
Why?
|
| Preceptorship | 1 | 2008 | 35 | 0.080 |
Why?
|
| HIV Seropositivity | 1 | 2009 | 144 | 0.080 |
Why?
|
| Medically Underserved Area | 1 | 2008 | 101 | 0.080 |
Why?
|
| Middle Aged | 6 | 2018 | 86204 | 0.080 |
Why?
|
| Risk-Taking | 2 | 2018 | 133 | 0.080 |
Why?
|
| Humans | 14 | 2023 | 261506 | 0.080 |
Why?
|
| Community Health Services | 1 | 2008 | 126 | 0.070 |
Why?
|
| Vulnerable Populations | 1 | 2008 | 167 | 0.070 |
Why?
|
| Female | 9 | 2019 | 141928 | 0.070 |
Why?
|
| Hospitals | 1 | 2009 | 485 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 4314 | 0.060 |
Why?
|
| Bisexuality | 1 | 2023 | 17 | 0.060 |
Why?
|
| Prospective Studies | 1 | 2018 | 12873 | 0.060 |
Why?
|
| Students, Medical | 1 | 2008 | 399 | 0.060 |
Why?
|
| Cohort Studies | 1 | 2015 | 9244 | 0.050 |
Why?
|
| Primary Health Care | 1 | 2008 | 787 | 0.050 |
Why?
|
| United States | 4 | 2019 | 15433 | 0.050 |
Why?
|
| Los Angeles | 1 | 2019 | 31 | 0.040 |
Why?
|
| Safe Sex | 1 | 2019 | 19 | 0.040 |
Why?
|
| New Jersey | 2 | 2009 | 35 | 0.040 |
Why?
|
| Cities | 1 | 2018 | 49 | 0.040 |
Why?
|
| Social Stigma | 1 | 2019 | 73 | 0.040 |
Why?
|
| Chicago | 1 | 2018 | 40 | 0.040 |
Why?
|
| Tablets | 1 | 2018 | 53 | 0.040 |
Why?
|
| Trust | 1 | 2019 | 99 | 0.040 |
Why?
|
| Health Surveys | 1 | 2019 | 402 | 0.040 |
Why?
|
| Epidemics | 1 | 2018 | 63 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2019 | 497 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2023 | 2803 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 5687 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2018 | 37905 | 0.030 |
Why?
|
| Sexual Behavior | 1 | 2018 | 310 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 1258 | 0.030 |
Why?
|
| Social Support | 1 | 2018 | 560 | 0.030 |
Why?
|
| Toxoplasmosis, Cerebral | 1 | 2014 | 4 | 0.030 |
Why?
|
| Trypanocidal Agents | 1 | 2014 | 26 | 0.030 |
Why?
|
| Nitroimidazoles | 1 | 2014 | 100 | 0.030 |
Why?
|
| Referral and Consultation | 1 | 2019 | 899 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2018 | 492 | 0.030 |
Why?
|
| Aged | 1 | 2018 | 70117 | 0.030 |
Why?
|
| Trypanosoma cruzi | 1 | 2014 | 221 | 0.020 |
Why?
|
| Logistic Models | 1 | 2018 | 3441 | 0.020 |
Why?
|
| Prevalence | 1 | 2018 | 3260 | 0.020 |
Why?
|
| Appointments and Schedules | 1 | 2008 | 98 | 0.020 |
Why?
|
| Program Development | 1 | 2008 | 261 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2008 | 672 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 4744 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2009 | 1320 | 0.010 |
Why?
|
| Risk Factors | 1 | 2018 | 17523 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 7573 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2014 | 32848 | 0.010 |
Why?
|
| Child | 1 | 2008 | 29154 | 0.000 |
Why?
|